Hikma Pharmaceutical reported 255M in Operating Profit for its second fiscal semester of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
AstraZeneca AZN:LN -292000000 1.38B
Bayer BAYN:GR 2.02B 1.49B
Fresenius FRE:GR € 1123M 115M
Genmab GEN:DC 514M 295M
GRIFOLS GRF:SM € 250.6M 37.64M
Hikma Pharmaceutical HIK:LN 255M 88M
Lonza Group LONN:SW 534M 217M
Orion ORNBV:FH 39.9M 17.4M
Recordati REC:IM 122.56M 2.92M